Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global In-Vitro Toxicology Testing Market

  • MAR2979399
  • 231 Pages
  • May 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In-vitro Toxicology Testing is the scientific analysis of the effects of toxic chemical substances on mammalian cells or cultured bacteria. In vitro (which means in glass) testing methods are used mainly to identify potentially harmful chemicals and/or to confirm the dearth of certain toxic properties in the early stages of the development of potentially useful new products such as agricultural chemicals, therapeutic drugs, and food additives. The In-vitro Toxicology Testing Market was valued at USAD XXX Billion in 2016 and is expected to reach USAD XXX Billion by 2021, at a CAGR of XX% between 2016 and 2021.

Other uses of In vitro toxicity testing include confirming the lack of toxicity, providing useful data information to elucidate toxicity generation and its mechanism and allows to save the time by clearing toxicological elements in the early phase of drug discovery process. In vitro toxicity testing allows for potential optimization of the concentration ranges in respect to toxic doses.

Market Dynamics

Cosmetics industry is gaining prevalence but a major part of the industry involves testing cosmetics in vivo. But with increasing awareness about animal rights and government support like the amendment of the European Union's Cosmetic Directive, animal testing has been banned. This is the major driver of the global in vitro toxicology testing market. Apart from this increasing R&D in this technology, technological advances. Increased funds form the government are other factors driving this industry.

However, the strict regulatory framework and rules, dearth of skilled professionals in the field of invitro toxicology testing, inability to establish the minute intricacies of in vivo through invitro, dearth of in vitro models to identify certain anomalies and endpoints are a major hinderance to the growth of this industry.

Market Segmentation

The In-vitro Toxicology Testing market is segmented on the basis of type, technology, product, method, application, dose, end users and geography. The detailed segmentation of the global market is given below:

--> On the basis of Type

> ADME (pharmacokinetics)

> Toxic Substance

> Dose

--> On the basis of Technology

> High Throughput Technology

> Molecular Imaging

> Cell Culture Technology

> Toxicogenomic

> Proteomics

> Omics Technology

> Metabolomics

Among these the Toxicogenomic segment is expected to grow at highest CAGR in the global market.

On the basis of Product

--> Assay

> A Cell Based ELISA and Western Blots

> Enzyme Toxicity Assay

> Receptor Binding Assay

> Bacterial Toxicity Assay

> Tissue Culture Assay

--> Lab Ware

--> Reagents

--> Services

Among these cell based assays is expected to grow at the highest CAGR as it is has become an essential in the drug discovery process mainly through High throughput screening.

--> On the basis of Method

> Biochemical

> In Silico Methods

> Ex Vivo Model

Among these the Ex Vivo Model is expected to show the highest growth owing to its increased adoption in cosmetics industry as an alternative to testing of cosmetics and household products on animals.

On the basis of Application

--> Systemic Toxicity

--> Carcinogenicity

--> Skin Sensitization and Irritation

--> Dermal Toxicity

--> Organ Toxicity

--> Neurotoxicity

--> Ocular Toxicity

On the basis of Dose

--> Threshold Response

--> Dose Response

On the basis of End Users

--> Cosmetics and Household Products

--> Pharmaceutical Industry Diagnostics

--> Chemical Industry

--> Food Industry

On the basis of Geography

--> North America

--> Europe

--> Asia Pacific

--> LAME

Geographic Analysis

Geographically the market is segmented into three different regions: north America, Europe, Asia Pacific, Latin America, Middle east and Africa. North America and Europe lead the market for invitro toxicology testing owing to the increased awareness and demand for this technology which has led to its easy adoption, collaborations between foreign and local laboratories which has increased the innovation in the field. Apart from this the increased prevalence of cosmetic industry in Europe have made it the major market holder. However, Asia Pacific is expected to show the greatest growth in future in the global market for invitro toxicology testing owing to the government support for the technology in the region. Apart from this China is going to be the market driver in the Asia Pacific region as the pressure on Chinese to ban animal testing is increasing which has led to increased awareness and investment in invitro toxicology testing. China and India also have increased R&D in biopharmaceutical sector and low development costs which will again boost the market in Asia Pacific.

Key Players

The key players who are driving the market of In-vitro Toxicology Testing and determine its future are: Agilent Technologies, Inc., Bio Reliance, Inc., Alere, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc.(USA). Other players in the in-vitro toxicology testing market include Accelrys, Inc., Molecular Toxicology Inc., MatTek Corporation, Xenometrix AG, and Quest Diagnostics Incorporation, Cyprotex (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding's subsidiary, USA), Eurofins Scientific SE (Luxembourg), SGS SA (Switzerland), Promega Corporation (USA), Merck KGaA (Germany), GE Healthcare (USA), Charles River Laboratories, Inc. (USA), and Lonza Group Ltd. (Switzerland).

The report contains comprehensive analysis on:

--> In-vitro Toxicology Testing market segments

--> In-vitro Toxicology Testing market drivers, restraints and opportunities

--> In-vitro Toxicology Testing market size and forecast 2016 to 2022

--> Supply and demand value chain

--> In-vitro Toxicology Testing market current trends

--> Competition and major companies

--> Technology and R&D status

--> Porters five force analysis

--> Strategic and critical success factor analysis of key players

The regional analysis of In-vitro Toxicology Testing market includes:

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights:

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390